Royal Bank of Canada
SKIN icon

Royal Bank of Canada’s SkinHealth Systems SKIN Stock Holding History

Royal Bank of Canada’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9K Buy
10,102
+3,031
+43% +$3.72K ﹤0.01% 6223
2025
Q4 		$10K Sell
7,071
-158,160
-96% -$229K ﹤0.01% 6428
2025
Q3 		$328K Sell
165,231
-25,570
-13% -$51.9K ﹤0.01% 4769
2025
Q2 		$364K Buy
190,801
+189,547
+15,115% +$267K ﹤0.01% 4711
2025
Q1 		$2K Sell
1,254
-5,744
-82% -$8.76K ﹤0.01% 6590
2024
Q4 		$11K Sell
6,998
-2,129
-23% -$3.35K ﹤0.01% 6327
2024
Q3 		$13K Sell
9,127
-20,591
-69% -$33.7K ﹤0.01% 6270
2024
Q2 		$57K Buy
29,718
+22,526
+313% +$63.4K ﹤0.01% 5587
2024
Q1 		$32K Sell
7,192
-20,621
-74% -$67K ﹤0.01% 5716
2023
Q4 		$86K Buy
27,813
+13,620
+96% +$51.1K ﹤0.01% 5714
2023
Q3 		$85K Buy
14,193
+5,260
+59% +$36.9K ﹤0.01% 5491
2023
Q2 		$75K Sell
8,933
-776
-8% -$8.06K ﹤0.01% 5544
2023
Q1 		$123K Sell
9,709
-13,467
-58% -$156K ﹤0.01% 5016
2022
Q4 		$212K Buy
23,176
+15,476
+201% +$167K ﹤0.01% 4829
2022
Q3 		$91K Buy
7,700
+1,430
+23% +$18.1K ﹤0.01% 5368
2022
Q2 		$80K Sell
6,270
-7,660
-55% -$103K ﹤0.01% 5486
2022
Q1 		$235K Sell
13,930
-13,454
-49% -$222K ﹤0.01% 4945
2021
Q4 		$661K Buy
27,384
+62
+0.2% +$1.6K ﹤0.01% 4232
2021
Q3 		$710K Buy
27,322
+20,960
+329% +$461K ﹤0.01% 4018
2021
Q2 		$106K Buy
6,362
+3,971
+166% +$54.3K ﹤0.01% 5567
2021
Q1 		$26K Buy
2,391
+141
+6% +$1.55K ﹤0.01% 6282
2020
Q4 		$25K Buy
+2,250
New +$24.2K ﹤0.01% 5966

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Royal Bank of Canada's SKIN Position: Q1 2026 in Review

Royal Bank of Canada increased its SkinHealth Systems (SKIN) stake by 43% in Q1 2026, buying an estimated $3.72K and bringing the position to 10,102 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #6223.

Royal Bank of Canada first reported a position in SKIN in Q4 2020 and has held it in 22 quarters since. The position peaked at $710K in Q3 2021. 116 funds tracked by Wall St. Rank hold SKIN as of Q1 2026.

  • Royal Bank of Canada held 10,102 shares of SkinHealth Systems worth $9K as of Q1 2026.
  • Royal Bank of Canada bought 3,031 SkinHealth Systems shares in Q1 2026, an estimated $3.72K.
  • SkinHealth Systems made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6223 holding.
  • Royal Bank of Canada first reported a position in SkinHealth Systems in Q4 2020 and has held it in 22 quarters since.
  • Royal Bank of Canada's SkinHealth Systems position peaked at $710K in Q3 2021.
  • 116 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.